Literature DB >> 21666078

MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration.

Zhenfeng Duan1, Edwin Choy, David Harmon, Xianzhe Liu, Michiro Susa, Henry Mankin, Francis Hornicek.   

Abstract

microRNAs (miRNA, miR) play an important role in cancer cell growth and migration; however, the potential roles of miRNAs in osteosarcoma remain largely uncharacterized. By applying a miRNA microarray platform and unsupervised hierarchical clustering analysis, we found that several miRNAs have altered expression levels in osteosarcoma cell lines and tumor tissues when compared with normal human osteoblasts. Three miRNAs, miR-199a-3p, miR-127-3p, and miR-376c, were significantly decreased in osteosarcoma cell lines, whereas miR-151-3p and miR-191 were increased in osteosarcoma cell lines in comparison with osteoblasts. Transfection of precursor miR-199a-3p into osteosarcoma cell lines significantly decreased cell growth and migration, thus indicating that the inhibition effect is associated with an increase in the G(1)-phase and a decrease of the S-phase cell population. In addition, we observed decreased mTOR and Stat3 expression in miR-199a-3p transfected cells. This study provides new insights for miRNAs in osteosarcoma and suggests that miR-199a-3p may play a functional role in osteosarcoma cell growth and proliferation. Restoring miR-199a-3p's function may provide therapeutic benefits in osteosarcoma. ©2011 AACR

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21666078      PMCID: PMC3711153          DOI: 10.1158/1535-7163.MCT-11-0096

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN: 1535-7163            Impact factor:   6.261


  31 in total

Review 1.  Targeting multiple arms of the apoptotic regulatory machinery.

Authors:  Yun Dai; Steven Grant
Journal:  Cancer Res       Date:  2007-04-01       Impact factor: 12.701

2.  Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing.

Authors:  J Carmichael; W G DeGraff; A F Gazdar; J D Minna; J B Mitchell
Journal:  Cancer Res       Date:  1987-02-15       Impact factor: 12.701

3.  SD-1029 inhibits signal transducer and activator of transcription 3 nuclear translocation.

Authors:  Zhenfeng Duan; James E Bradner; Edward Greenberg; Ross Levine; Rosemary Foster; Jennifer Mahoney; Michael V Seiden
Journal:  Clin Cancer Res       Date:  2006-11-15       Impact factor: 12.531

4.  MicroRNA signatures in human ovarian cancer.

Authors:  Marilena V Iorio; Rosa Visone; Gianpiero Di Leva; Valentina Donati; Fabio Petrocca; Patrizia Casalini; Cristian Taccioli; Stefano Volinia; Chang-Gong Liu; Hansjuerg Alder; George A Calin; Sylvie Ménard; Carlo M Croce
Journal:  Cancer Res       Date:  2007-09-15       Impact factor: 12.701

5.  MicroRNA expression signature of human sarcomas.

Authors:  S Subramanian; W O Lui; C H Lee; I Espinosa; T O Nielsen; M C Heinrich; C L Corless; A Z Fire; M van de Rijn
Journal:  Oncogene       Date:  2007-10-08       Impact factor: 9.867

6.  Tumor suppression by RNA from the 3' untranslated region of alpha-tropomyosin.

Authors:  F Rastinejad; M J Conboy; T A Rando; H M Blau
Journal:  Cell       Date:  1993-12-17       Impact factor: 41.582

Review 7.  Novel therapeutic agents for osteosarcoma.

Authors:  Kathleen O'Day; Richard Gorlick
Journal:  Expert Rev Anticancer Ther       Date:  2009-04       Impact factor: 4.512

8.  Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability.

Authors:  F Denizot; R Lang
Journal:  J Immunol Methods       Date:  1986-05-22       Impact factor: 2.303

9.  Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival.

Authors:  Jinmai Jiang; Yuriy Gusev; Ileana Aderca; Teresa A Mettler; David M Nagorney; Daniel J Brackett; Lewis R Roberts; Thomas D Schmittgen
Journal:  Clin Cancer Res       Date:  2008-01-15       Impact factor: 12.531

10.  The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.

Authors:  Can Liu; Kevin Kelnar; Bigang Liu; Xin Chen; Tammy Calhoun-Davis; Hangwen Li; Lubna Patrawala; Hong Yan; Collene Jeter; Sofia Honorio; Jason F Wiggins; Andreas G Bader; Randy Fagin; David Brown; Dean G Tang
Journal:  Nat Med       Date:  2011-01-16       Impact factor: 53.440

View more
  111 in total

1.  MicroRNA-125b-5p mediates post-transcriptional regulation of hepatitis B virus replication via the LIN28B/let-7 axis.

Authors:  Wanyu Deng; Xiaoyong Zhang; Zhiyong Ma; Yong Lin; Mengji Lu
Journal:  RNA Biol       Date:  2017-03-07       Impact factor: 4.652

2.  miR-199a-3p negatively regulates the progression of osteosarcoma through targeting AXL.

Authors:  Rui Tian; Xianbiao Xie; Ju Han; Canqiao Luo; Bicheng Yong; Huizhi Peng; Jingnan Shen; Tingsheng Peng
Journal:  Am J Cancer Res       Date:  2014-11-19       Impact factor: 6.166

Review 3.  MicroRNA in intervertebral disc degeneration.

Authors:  Zheng Li; Xin Yu; Jianxiong Shen; Matthew T V Chan; William Ka Kei Wu
Journal:  Cell Prolif       Date:  2015-03-04       Impact factor: 6.831

Review 4.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

Review 5.  Emerging roles of non-coding RNAs in the pathogenesis, diagnosis and prognosis of osteosarcoma.

Authors:  Chongchong Wang; Juehua Jing; Li Cheng
Journal:  Invest New Drugs       Date:  2018-08-06       Impact factor: 3.850

Review 6.  From wavy hair to naked proteins: the role of transforming growth factor alpha in health and disease.

Authors:  Bhuminder Singh; Robert J Coffey
Journal:  Semin Cell Dev Biol       Date:  2014-03-12       Impact factor: 7.727

7.  Serum levels of microRNA-133b and microRNA-206 expression predict prognosis in patients with osteosarcoma.

Authors:  Chun Zhang; Cong Yao; Haopeng Li; Guoyu Wang; Xijing He
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

Review 8.  Epigenetic alterations in osteosarcoma: promising targets.

Authors:  Binghao Li; Zhaoming Ye
Journal:  Mol Biol Rep       Date:  2014-02-06       Impact factor: 2.316

9.  Prognostic significance of miRNA-1 (miR-1) expression in patients with chordoma.

Authors:  Zhenfeng Duan; Jacson Shen; Xiaoqian Yang; Pei Yang; Eiji Osaka; Edwin Choy; Gregory Cote; David Harmon; Yu Zhang; G Petur Nielsen; Dimitrios Spentzos; Henry Mankin; Francis Hornicek
Journal:  J Orthop Res       Date:  2014-02-05       Impact factor: 3.494

10.  The conglomeration of diagnostic, prognostic and therapeutic potential of serum miR-199a and its association with clinicopathological features in epithelial ovarian cancer.

Authors:  Mariyam Zuberi; Imran Khan; Gauri Gandhi; P C Ray; Alpana Saxena
Journal:  Tumour Biol       Date:  2016-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.